EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases


Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases



FASEB Journal 5(11): 2560-2566



ISSN/ISBN: 0892-6638

PMID: 1868980

DOI: 10.1096/fasebj.5.11.1868980

Recent advances in understanding antigen recognition at the level of the trimolecular complex have provided new approaches for selective immunotherapy. Many of these approaches have been applied successfully to the animal model experimental autoimmune encephalomyelitis, and some are being tested in the human disease multiple sclerosis. In addition, new approaches utilizing nonspecific modulation of immune function are being explored in animals and humans. Immunospecific therapy in autoimmune diseases will ultimately be based on understanding how the normal immune system maintains unresponsiveness to self and how this state of self-tolerance is broken. Strategies for specific immune intervention in human diseases based on components of the trimolecular complex will have to take into account the polymorphism of the major histocompatibility complex in humans and the degree of heterogeneity among autoimmune T cells that react with an autoantigen.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 018186643

Download citation: RISBibTeXText

Related references

The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease. Harefuah 123(3-4): 110-115, 1992

Regulation of experimental autoimmune encephalomyelitis: inhibition of adoptive experimental autoimmune encephalomyelitis by 'recovery-associated suppressor cells'. Journal of Neuroimmunology 53(2): 123-131, 1994

Reversal of autoimmune encephalomyelitis by membranes presenting myelin basic protein-associated class II MHC molecule as an approach to immunotherapy of organ-specific autoimmune diseases. European Journal of Immunology 20(2): 357-361, 1990

Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Immunology 94(3): 431-437, 1998

Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 30(12): 1688-1696, 2000

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. Anatomy and Cell Biology 45(4): 215-220, 2012

Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. Journal of Autoimmunity 5(4): 401-410, 1992

Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. Journal of Immunology 178(4): 2212-2220, 2007

Peptide immunotherapy in experimental autoimmune encephalomyelitis. Biomedical Journal 38(3): 206-214, 2015

Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. Journal of Immunology 171(1): 462-468, 2003

Peptide mediated immunotherapy in experimental autoimmune encephalomyelitis. Journal of Cellular Biochemistry Suppl (15 Part A): 286, 1991

Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clinical and Experimental Immunology 29(1): 100-109, 1977

Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 206(1-2): 22-27, 2008

Mechanisms of acquired thymic tolerance to experimental autoimmune encephalomyelitis Thymic dendritic cells induce peripheral T-cell unresponsiveness in vivo. Neurology 45(4 Suppl 4): A210-A211, 1995

Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis. European Journal of Immunology 37(12): 3576-3581, 2007